Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cost-effectiveness of adult pneumococcal vaccination: responding to: Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine 2012;30(August (36)):5437-44.

Autor: Grabenstein JD, O'Brien MA, Chen J

Publikováno v: Vaccine [Vaccine] 2013 Mar 15; Vol. 31 (12), pp. 1549. Date of Electronic Publication: 2012 Nov 12.

Refractory plasmonic material based floating solar still for simultaneous desalination and electricity generation.

Autor: Margeson MJ; Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, NS B3H 4R2, Canada., Atwood M; Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, NS B3H 4R2, Canada., Lara de Larrea J; Centre for Water Resources Studies, Department of Civil and Resource Engineering, Dalhousie University, 1360 Barrington Street, Halifax, NS B3H 4R2, Canada., Weatherby JA; Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, NS B3H 4R2, Canada., Daurie H; Centre for Water Resources Studies, Department of Civil and Resource Engineering, Dalhousie University, 1360 Barrington Street, Halifax, NS B3H 4R2, Canada., Near K; Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, NS B3H 4R2, Canada., Gagnon GA; Centre for Water Resources Studies, Department of Civil and Resource Engineering, Dalhousie University, 1360 Barrington Street, Halifax, NS B3H 4R2, Canada., Dasog M; Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, NS B3H 4R2, Canada.

Publikováno v: IScience [iScience] 2024 Oct 21; Vol. 27 (11), pp. 111225. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).

Cost-effectiveness of adult pneumococcal vaccination: responding to: Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine 2012;30(August (36)):5437-44

Autor: John D, Grabenstein, Megan A, O'Brien, Jieling, Chen

Publikováno v: Vaccine. 31(12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8502b20c27d8b1a442a8900904d0a1f3
https://pubmed.ncbi.nlm.nih.gov/23318148

Annual public health and economic burden of medically attended respiratory syncytial virus illnesses among US adults.

Autor: Averin A; Avalere Health, Boston, MA, USA. Electronic address: ahuva.averin@avalerehealth.com., Sato R; Pfizer Inc., Collegeville, PA, USA., Begier E; Pfizer Inc., Collegeville, PA, USA., Gessner BD; Pfizer Inc., Collegeville, PA, USA., Snow V; Pfizer Inc., Collegeville, PA, USA., Cane A; Pfizer Inc., Collegeville, PA, USA., Quinn E; Avalere Health, Boston, MA, USA., Atwood M; Avalere Health, Boston, MA, USA., Kijauskaite G; Avalere Health, Boston, MA, USA., Weycker D; Avalere Health, Boston, MA, USA.

Publikováno v: Vaccine [Vaccine] 2024 Sep 20; Vol. 42 (26), pp. 126323. Date of Electronic Publication: 2024 Sep 20.